Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior.
about
Animal models of suicide-trait-related behaviorsPerinatal vs genetic programming of serotonin states associated with anxiety.Molecular genetics of mouse serotonin neurons across the lifespan.Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.Serotonin: a regulator of neuronal morphology and circuitryPharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategyFluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat.Paradoxical anxiogenic response of juvenile mice to fluoxetineCoherent amygdalocortical theta promotes fear memory consolidation during paradoxical sleepHow the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure.Transient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult miceRisk of prenatal depression and stress treatment: alteration on serotonin system of offspring through exposure to Fluoxetine.Generation and phenotypic analysis of mice lacking all urea transporters.Long-Term Sertraline Intake Reverses the Behavioral Changes Induced by Prenatal Stress in Rats in a Sex-Dependent Way.Boron-Doped Diamond Microelectrodes Reveal Reduced Serotonin Uptake Rates in Lymphocytes from Adult Rhesus Monkeys Carrying the Short Allele of the 5-HTTLPR.Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats.Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior.Rapid eye movements during sleep in mice: high trait-like stability qualifies rapid eye movement density for characterization of phenotypic variation in sleep patterns of rodentsDNA methylation profiles within the serotonin transporter gene moderate the association of 5-HTTLPR and cortisol stress reactivityChronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains.Trick or treat? neurodevelopmental consequences of pharmacotherapy for affective disorders.Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention?Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetusDose-dependent effects of neonatal SSRI exposure on adult behavior in the rat.Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment.Differential serotonin transport is linked to the rh5-HTTLPR in peripheral blood cells.Transient postnatal fluoxetine decreases brain concentrations of 20-HETE and 15-epi-LXA4, arachidonic acid metabolites in adult mice.Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.Physiologically relevant changes in serotonin resolved by fast microdialysis.The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspringGenetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior.Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT3A and 5-HT6 receptor subtypes.Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient miceOf rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction.Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age.Anxiolytic profile of fluoxetine as monitored following repeated administration in animal rat model of chronic mild stress.Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.
P2860
Q24645693-6D36160C-55DC-43EE-A5B5-C84FF5E7197DQ27311047-34728088-3368-42D5-8564-3B3A4770F8CEQ27691374-1AAF7DA6-B3FD-4926-BE35-664A0C1BB547Q30395001-BA51E7F4-A442-473A-AE10-F43B141711D0Q30430944-77AFB8DC-85B5-4733-84B5-38CC629A0B5AQ30468153-E26051B0-2283-4D92-8D2B-6BAA2AFA9514Q30477109-BB6BBFE6-6B5B-40F3-A76E-C87DFD5F23B4Q30491364-0460ACF1-A74A-4AA1-BDCD-F3A19F23AD31Q30494022-F8E74821-4A57-442D-BCA5-498FEDD175ACQ30511878-2F7139E3-F3B1-4444-807A-059ED034C5CEQ30575789-73ABA015-BE50-4FD8-BA09-24D26586DB24Q30818739-F95FEE61-12EF-49EF-86D6-36ADC5678F14Q33653317-D83C5727-ADEA-4A3C-B33E-3C7FC17B68BEQ33734532-E25D71BD-DD9C-4CC3-8076-435EA089E70BQ33747022-D47B7723-75E8-40E3-94D1-520217026B27Q33843546-121D5CCD-F62E-4BDE-90A8-5DEA98F6D6CDQ33923651-BC7C752F-1420-4F76-9A29-50AC0E632539Q34065099-3FD75869-4B86-438C-B7A1-C30BBCB84786Q34370519-1608D807-B0C7-450F-8DEB-26DE095680CDQ34568610-FFF41138-41BB-4E87-A31E-BFEFDDFBB899Q34660949-EA205FA7-8334-472E-86BE-6C61A34DDD51Q34714284-7FBC5326-09C5-486E-97E4-38C39C6440A6Q35046638-0F391DBE-0BA6-4A63-B1E8-805A08ADAAC1Q35090255-CDC79CF0-B118-4BD3-95A7-238D009C9987Q35171321-F4B30F93-253F-4AC9-8080-EAD140484D5AQ35585165-211EBD64-5765-41E1-8D2C-DBF7DC01704AQ35679926-047F5B21-EFA9-40E4-960B-7D74566476ACQ35844326-95B85397-5AB0-4D33-A861-6DAF0BE63AF1Q36090348-876BD276-2489-4E7B-8B78-730FBDA6D9DAQ36213523-5E086907-3FAD-4B68-A7C2-E788D2B67830Q36851690-23829B34-15E2-47C1-8DD9-E141FD226EBEQ36860205-D642F01B-D8BD-4716-9F0B-3FE4BBC96DFDQ36921232-DA2CB26A-6993-4E77-8F15-7ABD151B33CDQ36939119-DFA2BB42-D9AC-44F8-A9FB-542DCF680C9AQ36975571-067FCCA4-05F5-473F-8FDB-51CB0392843EQ37058701-D51639B8-EF33-4F00-8A5C-9AA03404B78AQ37135654-F39D6E6E-0AB9-4829-8B68-8FB0E5FB564DQ37226375-290734E9-AF12-4426-B0C5-B0C914F8DCA4Q37330734-E5CDCBF2-0263-4A0D-9CF8-7DAC30F20D65Q37337705-252B6DA2-0C4C-4CF4-8259-160F16AF230E
P2860
Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Lasting syndrome of depression ...... m sleep, stress, and behavior.
@ast
Lasting syndrome of depression ...... m sleep, stress, and behavior.
@en
Lasting syndrome of depression ...... m sleep, stress, and behavior.
@nl
type
label
Lasting syndrome of depression ...... m sleep, stress, and behavior.
@ast
Lasting syndrome of depression ...... m sleep, stress, and behavior.
@en
Lasting syndrome of depression ...... m sleep, stress, and behavior.
@nl
prefLabel
Lasting syndrome of depression ...... m sleep, stress, and behavior.
@ast
Lasting syndrome of depression ...... m sleep, stress, and behavior.
@en
Lasting syndrome of depression ...... m sleep, stress, and behavior.
@nl
P1476
Lasting syndrome of depression ...... om sleep, stress, and behavior
@en
P2093
Chloé Alexandre
Joëlle Adrien
P304
P356
10.1523/JNEUROSCI.4006-07.2008
P407
P577
2008-04-01T00:00:00Z